By vgreene, 5 March, 2021 Doesn t require ultracold storage so easier to distribute and store uses a modified adenovirus unable to cause illness to deliver spike protein DNA that s more stable than mRNA vaccines that rely on lipid nanoparticles requiring ultracold temps for storag
By vgreene, 5 March, 2021 How does the Janssen COVID 19 Vaccine Johnson Johnson differ from the other 2 available COVID 19 vaccines
By vgreene, 4 March, 2021 Study considerations randomized but open label small sample size trial stopped early imbalanced baseline respiratory support and AZ use
By vgreene, 4 March, 2021 KEY FINDINGS TCZ SOC not superior to SOC for improving clinical outcomes at 15 days in severe or critical COVID 19 TCZ may incr mortality
By vgreene, 4 March, 2021 Effect of Tocilizumab on Clinical Outcomes at 15 days in Patients With Severe or Critical Coronavirus Disease 2019 Randomised Controlled Trial
